Erik Thorsby

Erik Thorsby's AcademicInfluence.com Rankings

Erik Thorsby

Philosophy

#4116

World Rank

#6510

Historical Rank

Logic

#1648

World Rank

#2451

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Erik Thorsby Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Erik Stein Thorsby was a Norwegian physician and professor at the University of Oslo and Oslo University Hospital. He carried out research in immunology, specializing in transplant immunology. Career Thorsby studied medicine at the University of Oslo and graduated in 1963. In 1969, he earned his doctorate in medicine.

(See a Problem?)

Erik Thorsby's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer (1989) (932)
Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients (1993) (598)
HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. (1993) (597)
HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation--a fast and reliable technique. (2008) (277)
Invited anniversary review: HLA associated diseases. (1997) (264)
Interferon-gamma enhances expression of secretory component, the epithelial receptor for polymeric immunoglobulins. (1987) (232)
Studies on Human Epidermal Langerhans Cells (1980) (217)
Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation (1995) (206)
Human Transplantation Antigens (1972) (205)
HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease. (1982) (199)
HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. (2005) (189)
T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. (1994) (187)
The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. (1999) (185)
HLA‐DR‐like Antigens in the Epithelium of the Human Small Intestine (1980) (184)
Influence of in Vivo Hydrocortisone on Some Human Blood Lymphocyte Subpopulations (1981) (174)
On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. (1993) (169)
Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. (2007) (169)
Antigen Presentation by Vascular Endothelial Cells and Epidermal Langerhans Cells: The Role of HLA‐DR (1982) (167)
The peptide binding motif of the disease associated HLA‐DQ (α 1* 0501, β 1* 0201) molecule (1996) (167)
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases (2005) (163)
HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations. (1999) (162)
HLA-Encoded Genetic Predisposition in IDDM: DR4 Subtypes May Be Associated With Different Degrees of Protection (1997) (161)
Antigen-presenting properties of human vascular endothelial cells. (1980) (155)
Gliadin Specific, HLA DQ2‐Restricted T Cells are Commonly Found in Small Intestinal Biopsies from Coeliac Disease Patients, but not from Controls (1997) (152)
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus. (1989) (150)
Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. (1991) (149)
HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. (1991) (149)
HLA-DR and -DQ genotypes of celiac disease patients serologically typed to be non-DR3 or non-DR5/7. (1992) (141)
Isolation of pure functionally active CD8+ T cells. Positive selection with monoclonal antibodies directly conjugated to monosized magnetic microspheres. (1986) (141)
Macrophage‐Dependent Response of Immune Human T Lymphocytes to PPD In Vitro Influence of HLA‐D Histocompatibility (1977) (138)
HLA‐D Restriction of the Macrophage‐Dependent Response of Immune Human T Lymphocytes to PPD in Vitro: Inhibition by Anti‐HLA‐DR Antisera (1978) (138)
HLA complex genes in type 1 diabetes and other autoimmune diseases. Which genes are involved? (2001) (135)
CHARACTERIZATION OF CD34+ PERIPHERAL BLOOD CELLS FROM HEALTHY ADULTS MOBILIZED BY RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR (1994) (131)
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms (2007) (126)
Distribution of HLA class II alleles among Norwegian Caucasians. (1990) (124)
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (α1*0501, (β1*02) or the HLA-DQ (α1*03, (β1*0302) heterodimers (1997) (119)
A short history of HLA. (2009) (116)
Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus (1993) (116)
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase I/II study (1996) (115)
Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease (2004) (115)
HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. (1980) (115)
Identification of a putative motif for binding of peptides to HLA-DQ2. (1996) (107)
A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. (1999) (106)
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6 (1976) (103)
Patients with multiple sclerosis carry DQB1 genes which encode shared polymorphic amino acid sequences. (1989) (102)
THE HUMAN MIXED LYMPHOCYTE‐ENDOTHELIUM CULTURE INTERACTION (1975) (101)
HLA‐D Region Molecules Restrict Proliferative T Cell Responses to Antigen (1982) (97)
Immunogenetics as a tool in anthropological studies (2011) (96)
Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin‐dependent diabetes mellitus (1993) (94)
Genomic hybridization with class II transplantation antigen cDNA probes as a complementary technique in tissue typing. (1984) (93)
p21‐ras‐peptide‐specific T‐cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp) (2007) (93)
Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. (2007) (93)
Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. (1997) (92)
Several genes in the extended human MHC contribute to predisposition to autoimmune diseases. (2005) (89)
HLA antigens in juvenile arthritis (1983) (89)
HL-A antigens and susceptibility to diseases. A study of patients with acute lymphoblastic leukaemia, Hodgkin's disease, and childhood asthma. (2008) (89)
Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen‐specific T‐cell responses (1983) (88)
Function of DQ2 and DQ8 as HLA susceptibility molecules in celiac disease. (1994) (87)
Direct immunomagnetic quantification of lymphocyte subsets in blood. (1988) (80)
Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61). (1992) (79)
T lymphocyte recognition of a celiac disease-associated cis- or trans-encoded HLA-DQ alpha/beta-heterodimer. (1990) (77)
Expression of Major Histocompatibility Complex Class II Subregion Products by Jejunal Epithelium in Patients with Coeliac Disease (1987) (76)
Relation between HLA-DR-like antigens and secretory component (SC) in jejunal epithelium of patients with coeliac disease or dermatitis herpetiformis. (1981) (75)
Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and –DRB1 (2003) (75)
Beta-2-microglobulin. Part of the HL-A molecule in the cell membrane. (2008) (74)
Induction of Various HLA Class II Molecules in a Human Colonic Adenocarcinoma Cell Line (1987) (73)
T cells recognize a peptide derived from α-gliadin presented by the celiac disease-associated HLA-DQ (α1∗0501, β1∗0201) heterodimer (1994) (73)
T Cells from the Peripheral Blood of Coeliac Disease Patients Recognize Gluten Antigens when Presented by HLA‐DR, ‐DQ, or ‐DP Molecules (1994) (72)
Susceptibility to develop celiac disease is primarily associated with HLA-DQ alleles. (1990) (72)
HLA-MATCHING AND PRETRANSPLANT BLOOD TRANSFUSIONS IN CADAVERIC RENAL TRANSPLANTATION—A CHANGING PICTURE WITH CYCLOSPORIN (1986) (72)
Cell mediated lympholysis: CML. a microplate technique requiring few target cells and employing a new method of supernatant collection. (1977) (70)
Studies on human epidermal Langerhans' cells: II. Activation of human T lymphocytes to herpes simplex virus. (1980) (70)
Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. (1997) (70)
Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis. (2006) (68)
The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule. (1996) (68)
EVIDENCE FOR A PRIMARY ASSOCIATION OF CELIAC DISEASE TO A PARTICULAR HLA-DQ a/ß HETERODIMER (2003) (67)
Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis (2007) (67)
Studies on Human Epidermal Langerhans Cells (1982) (67)
T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides. (1992) (67)
Cell Specific and Common Antigens on Human Granulocytes and Lymphocytes Demonstrated with Cytotoxic Hetero‐Antibodies (1967) (66)
HLA antigens in dermatitis herpetiformis and coeliac disease. (2008) (64)
The primary association of celiac disease to a given HLA‐DQ α/β heterodimer explains the divergent HLA‐DR associations observed in various Caucasian populations (1990) (64)
Enriched epidermal Langerhans cells are potent antigen-presenting cells for T cells. (1984) (63)
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region (1977) (63)
The association between rheumatoid arthritis and the HLA antigen DR4. (1983) (63)
Strong association between the HLA-Dw3-related B cell alloantigen -DRw3 and coeliac disease. (1978) (63)
Heterogeneous reactivity patterns of HLA-DQ-restricted, small intestinal T-cell clones from patients with celiac disease. (1997) (62)
T cell clones specific for p21 ras‐derived peptides: Characterization of their fine specificity and HLA restriction (1993) (62)
HLA DR antigens and gold toxicity. (1983) (62)
Fine mapping of the diabetes-susceptibility locus, IDDM4, on chromosome 11q13. (1998) (61)
Evidence for a type 1 diabetes susceptibility locus (IDDM10) on human chromosome 10p11-q11. (1997) (61)
SPECIFIC DESTRUCTION OF HUMAN ENDOTHELIAL CELL MONOLAYERS BY ANTI‐DRw ANTISERA (1979) (60)
The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from the 1858C>T association in a Norwegian rheumatoid arthritis material. (2007) (60)
Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis (2007) (60)
Myeloid differentiation of purified CD34+ cells after stimulation with recombinant human granulocyte-monocyte colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and interleukin-3. (1991) (59)
Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. (1990) (58)
Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. (1995) (57)
The recombination fraction of the HL-A system. (2008) (56)
Killer immunoglobulin‐like receptor ligand HLA‐Bw4 protects against multiple sclerosis (2009) (56)
The human major histocompatibility system. (1974) (56)
On the localization of the Gb locus within the MHS region of chromosome No. 6. (1975) (55)
HLA‐RESTRICTED CYTOTOXICITY AGAINST MALE‐SPECIFIC (H‐Y) ANTIGEN AFTER ACUTE REJECTION OF AN HLA‐IDENTICAL SIBLING KIDNEY CLONAL DISTRIBUTION OF THE CYTOTOXIC CELLS (1982) (54)
HLA‐Dr‐Expressing Langerhans'‐Like Cells in Vaginal and Cervical Epithelium (1983) (54)
HLA matching of unrelated bone marrow transplant pairs: direct sequencing of in vitro amplified HLA-DRB1 and -DQB1 genes using magnetic beads as solid support. (1993) (53)
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule (1994) (53)
Serological identification of five HLA-D associated (Ia-like) determinants. (2008) (53)
Particular HLA-DQ αβ Heterodimer Associated With IDDM Susceptibility in Both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 Whites (1991) (52)
Importance of HLA-DR matching in cadaveric renal transplantation: a prospective one-center study of 170 transplants. (1980) (52)
Human transplantation antigens. Appendix: current methods in histocompatibility testing. (1969) (51)
Repeated platelet transfusions from HL-A compatible unrelated and sibling donors. (2008) (50)
Activation of Human Suppressor Cells in Mixed Lymphocyte Cultures (1977) (50)
Transmission of haplotypes of microsatellite markers rather than single marker alleles in the mapping of a putative type 1 diabetes susceptibility gene (IDDM6). (1998) (49)
Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami. (2007) (48)
Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes (2006) (48)
Rga (Rodgers) and the HLA region: linkage and associations. (2008) (48)
Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex (2009) (48)
HL-A antigens and susceptibility to diseases. II. Leprosy. (2008) (47)
Inhibition of the Fc receptor of human lymphoid cells by antisera- recognizing determinants of the hla system (1976) (47)
HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. (1993) (46)
A K‐ras 13GLY → ASP mutation is recognized by HLA‐DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation? (1994) (46)
Genome-wide Ancestry Patterns in Rapanui Suggest Pre-European Admixture with Native Americans (2014) (46)
DR- and DQ-associated protection from type 1A diabetes: comparison of DRB1*1401 and DQA1*0102-DQB1*0602*. (2000) (46)
CD4+ T cells with specific reactivity against astrovirus isolated from normal human small intestine. (1998) (45)
Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis (2007) (45)
The role of HLA in T cell activation. (1984) (45)
HLA antigens and cervical carcinoma (1992) (44)
On the orientation of the HL-A region and the PGM3 locus in the chromosome. (2008) (44)
HLA antigens in multiple sclerosis (1977) (43)
Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. (1994) (43)
Stimulation of T lymphocytes by autologous non-T lymphoid cells. Participation of HLA-D? (2008) (43)
[One year experience with cyclosporin A in clinical heart transplantation]. (1985) (42)
HL—A Antigens and Genes (1969) (42)
The antigen-presenting function of human Langerhans cells. (1984) (42)
Binding of peptides from the N-terminal region of alpha-gliadin to the celiac disease-associated HLA-DQ2 molecule assessed in biochemical and T cell assays. (1996) (41)
HLA-DRw4 AND RHEUMATOID ARTHRITIS (1979) (40)
Both α and β chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with β chain residues being most influential (1996) (40)
HLA DR antigens in rheumatoid arthritis. (1983) (39)
The HL-A system: evidence of a third sub-locus. (2009) (39)
Cell-mediated lymphocytotoxicity directed against HLA-D gene products. (1979) (39)
Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. (1992) (39)
Scandiatransplant: preliminary report of a kidney exchange program. (1971) (38)
Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes. (2007) (38)
Presence of HLA-D determinants on human macrophages (1976) (38)
Mixed Lymphocyte Cultures and HL-A Identity in Unrelated Subjects (1970) (38)
A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man. (1985) (38)
The HLA‐DQ(α1*0102, β1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA‐DR(α1*01, β1*1501) heterodimer (1997) (38)
HLA associations in type 1 diabetes among patients not carrying high-risk DR3-DQ2 or DR4-DQ8 haplotypes. (1999) (38)
T lymphocyte subset changes in human immunodeficiency virus infection. (1989) (38)
The proliferative T cell response to herpes simplex virus (HSV) antigen is restricted by self HLA-D. (1980) (37)
Further evidence of a third HL-A locus. (2008) (37)
A second locus determining human MLC response: separate lymphocyte populations recognize the products of each different MLC-locus allele in allogeneic combinations. (1973) (37)
Antigen‐Specific Proliferative Human T‐Lymphocyte Clones with Specificity for Chlamydia trachomatis (1983) (37)
Gliadin‐Specific T Cell Responses in Peripheral Blood of Healthy Individuals Involve T Cells Restricted by the Coeliac Disease Associated DQ2 Heterodimer (1995) (36)
HLA-DQ antigens and DQ beta amino acid 57 of Japanese patients with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. (1989) (36)
Identification of five lymphocyte activating determinants in man. (2008) (36)
Stimulation of human lymphocytes by allogeneic endothelial cells in vitro. (2008) (36)
Characterisation of immune responses in pancreatic carcinoma patients after mutant p21 ras peptide vaccination. (1996) (35)
The relation of parental sex and age to recombination in the HL-A system. (1973) (34)
HLA-DR mismatch and histologically evaluated rejection episodes in cardiac transplants can be correlated. (1988) (34)
Vascular and renal distribution of HLA--DR-like antigens. (1981) (34)
Typing for HLA-D determinants. comparison of typing results using homozygous stimulating cells and primed cultures. (2008) (34)
An increased risk of insulin-dependent diabetes mellitus (IDDM) among HLA-DR4,DQw8/DRw8,DQw4 heterozygotes. (1989) (34)
β-2-Microglobulin is part of the HL-A molecule in the lymphocyte membrane (1974) (34)
Narcolepsy and the HLA system. (2001) (34)
T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA (1994) (33)
Possible Detection of HLA‐DR Alloantigenic Specificities in Man with Unabsorbed Rabbit Antisera (1978) (33)
Molecular genetic studies of natives on Easter Island: evidence of an early European and Amerindian contribution to the Polynesian gene pool. (2007) (33)
A strong impact of matching for a limited number of HLA-DR antigens on graft survival and rejection episodes: a single-center study of first cadaveric kidneys to nonsensitized recipients. (1998) (33)
Class‐II HLA Restriction of Antigen‐Specific Human T‐Lymphocyte Clones (1983) (33)
The human major histocompatibility complex HLA: some recent developments. (1979) (33)
A Haemolytically Non-Active C4 Gene Products (1980) (32)
HLA-DR ANTIGEN MATCHING IN CADAVER RENAL TRANSPLANTATION (1978) (32)
Polymorphisms in the cathepsin L2 (CTSL2) gene show association with type 1 diabetes and early-onset myasthenia gravis. (2007) (32)
The FCRL3 −169T>C polymorphism is associated with rheumatoid arthritis and shows suggestive evidence of involvement with juvenile idiopathic arthritis in a Scandinavian panel of autoimmune diseases (2007) (32)
Polymorphism of human major histocompatibility complex-encoded transporter associated with antigen processing (TAP) genes and susceptibility to juvenile rheumatoid arthritis. (1994) (32)
Juvenile idiopathic arthritis (JIA) is primarily associated with HLA-DR8 but not DQ4 on the DR8-DQ4 haplotype (2002) (32)
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. (1970) (32)
Identification of four SB antigens by cloned cells. Population studies of Norwegians. (2008) (32)
New HL‐A Alleles (1970) (31)
Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients (2005) (31)
The Polynesian gene pool: an early contribution by Amerindians to Easter Island (2012) (31)
Genetic association between juvenile rheumatoid arthritis and polymorphism in the SH2D2A gene (2004) (31)
HL-A genotypes of children with acute leukaemia. A family study. (2009) (31)
Structure and function of HLA molecules. (1987) (30)
Gene order and gene distances in the HLA region studied by the haplotype method (1983) (30)
Characterization of an HLA-DQ2-specific monoclonal antibody. Influence of amino acid substitutions in DQ beta 1*0202. (1995) (30)
Long-term changes in natural killer activity after external pelvic radiotherapy. (1981) (30)
Macrophage/T‐Lymphocyte Interaction in the Immune Response to PPD in Humans (1979) (30)
HLA‐D/DR Restriction of Macrophage‐dependent Antigen Activation of Immune T Lymphocytes: Cross‐reacting Allogeneic HLA‐D/DR May Partly Substitute for Self HLA‐D/DR (1980) (30)
No Independent Associations of LMP2 and LMP7 Polymorphisms With Susceptibility to Develop IDDM (1997) (29)
Microcytotoxic HLA typing of cells directly isolated from blood by means of antibody-coated microspheres. (1987) (29)
In Vitro Sensitization of Human T Lymphocytes to Hapten (TNP)‐Conjugated and Non‐treated Autologous Cells is Restricted by Self‐HLA‐D (1979) (29)
Recognition of a particular HLA‐DQ heterodimer by a human γ/δ T cell clone (1990) (29)
Gliadin Specific, HLA DQ2‐Restricted T Cells are Commonly Found in Small Intestinal Biopsies from Coeliac Disease Patients, but not from Controls (1997) (29)
HLA antigens in juvenile arthritis. Genetic basis for the different subtypes. (1983) (29)
No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus. (1995) (28)
HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. (1984) (28)
The clinical expression of hemochromatosis in Oslo, Norway. Excessive oral iron intake may lead to secondary hemochromatosis even in HFE C282Y mutation negative subjects. (2000) (28)
HLA profile of three ethnic groups living in the North-Western region of Russia. (2002) (28)
T cell responses to a Dermatophagoides farinae allergen preparation in allergics and healthy controls. (1986) (28)
Both DR and MT Class II HLA Molecules May Restrict Proliferative T‐Lymphocyte Responses to Antigen (1982) (28)
SIGNIFICANCE OF HLA-D/DR MATCHING IN RENAL TRANSPLANTATION (1978) (28)
A tentative new model for the organization of the mouse H‐2 histocompatibility system: Two segregant series of antigens (1971) (28)
A gene in the telomeric HLA complex distinct from HLA–A is involved in predisposition to juvenile idiopathic arthritis (2002) (28)
Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci. (2005) (27)
Biological function of HLA. (1978) (27)
The HLA Associated Predisposition to Type 1 Diabetes and Other Autoimmune Diseases (1996) (27)
HL-A antigens on human granulocytes studied with cytotoxic iso-antisera obtained by skin grafting. (2009) (27)
Human serum-induced expression of E-selectin on porcine aortic endothelial cells in vitro is totally complement mediated. (2001) (27)
Positive selection of activated T cells of the T8 (CD8) sub-type by immunomagnetic separation. (2008) (26)
HLA associations in insulin-dependent diabetes mellitus: no independent association to particular DP genes. (1997) (26)
Interaction between HLA-DR and HLA-DP, and between HLA and interleukin 1 alpha in juvenile rheumatoid arthritis indicates heterogeneity of pathogenic mechanisms of the disease. (1995) (26)
Coding Region Polymorphisms of Human T‐Cell Receptor Vβ6.9 and Vβ21.4 (1992) (26)
The polymorphism in the 3′ untranslated region of IL12B has a negligible effect on the susceptibility to develop type 1 diabetes in Norway (2001) (26)
EFFECTS OF HLA‐HAPLOIDENTICAL BLOOD TRANSFUSIONS ON DONOR‐SPECIFIC IMMUNE RESPONSIVENESS (1984) (26)
Isolation of pure and functionally active T4 and T8 cells by positive selection with antibody-coated monosized magnetic microspheres. (1987) (25)
Cross‐Reactive HL‐A Antibodies; Absorption and Immunization Studies (1970) (25)
T lymphocyte responses to Coxsackie B4 and mumps virus. II. Immunoregulation by HLA-DR3 and -DR4 associated restriction elements. (2008) (25)
Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells (1992) (25)
Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations. (1994) (25)
CD8+T cells from a patient with colon carcinoma, specific for a mutant p21-Ras-derived peptide (GLY13→ASP), are cytotoxic towards a carcinoma cell line harbouring the same mutation (1995) (25)
Influence of HLA-A, -B, -C, and -D matching on the outcome of clinical kidney transplantation. (1977) (25)
HLA antigens in epileptic patients with drug-induced immunodeficiency. (1982) (24)
Proliferative human T cell responses to Chlamydia trachomatis in vitro. (1983) (24)
Genetics of the HL‐A System A Population and Family Study (1970) (24)
Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis. (2006) (24)
HLA-D region products are expressed in endothelial cells. (2008) (24)
Refinement of the MHC Risk Map in a Scandinavian Primary Sclerosing Cholangitis Population (2014) (24)
HLA-DRB1, -DQA1, -DQB1, -DPA1 and -DPB1 genes in Japanese multiple sclerosis patients. (1991) (23)
The primary association of celiac disease to a given HLA-DQ alpha/beta heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations. (1990) (23)
T lymphocyte clones recognizing an HLA-DQw3.2-associated epitope involving residue 57 on the DQ beta chain. (1988) (23)
A human-human hybridoma producing cytotoxic antibody to HLA-B15, cross-reacting with B17, B5, B35 and B18. (2008) (23)
Application and interpretation of transmission/disequilibrium tests: transmission of HLA-DQ haplotypes to unaffected siblings in 526 families with type 1 diabetes. (2000) (23)
HLA restriction patterns of gliadin- and astrovirus-specific CD4+ T cells isolated in parallel from the small intestine of celiac disease patients. (1998) (23)
C3 polymorphism: Genetic linkage relations (1974) (23)
The Bf locus in the HLA region of chromosome 6: Linkage and association studies (1975) (23)
Reliable isolation of human immunodeficiency virus from cultures of naturally infected CD4+ T cells. (1989) (23)
Further evidence of an Amerindian contribution to the Polynesian gene pool on Easter Island. (2009) (22)
Activation of Resting, Pure CD4+, and CD8+ Cells via CD3 (1987) (22)
MLC-activating HLA-D determinants: identification, tissue distribution, and significance. (1977) (22)
Strong association between an HLA-Dw3 associated B cell alloantigen and dermatitis herpetiformis. (2008) (22)
DQCAR microsatellite polymorphisms in three selected HLA class II-associated diseases. (1995) (22)
Lymphocyte activating alloantigens on human epidermal cells. (2008) (22)
Specific in vitro elimination of histocompatibility antigen reactive cells (HARC). (1973) (21)
Localization of the human GLO gene locus (1976) (21)
HLA‐DR3‐ and HLA‐DR7‐Restricted T‐Cell Hyporesponsiveness to Gluten Antigen: A Clue to the Aetiology of Coeliac Disease? (1983) (21)
Lymphocytotoxic Antisera of Limited Iso‐Specificity After Skin Grafting in Man (1968) (20)
The HL-A system: antigenic heterogeneity and four new antigens. (2008) (20)
Accessory Cell‐Dependent T‐Cell Activation via Ti‐CD3 (1988) (20)
Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. (1979) (20)
The human mixed lymphocyte culture (MLC) interaction after in vivo alloimmunization. I. Kinetics. (1974) (20)
HLA associations in type 1 diabetes: merging genetics and immunology. (2001) (20)
Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP (SB) Class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodies. (1984) (20)
HLA-DR3 and -DR4 control T-lymphocyte responses to mumps and Coxsackie B4 virus: studies on patients with Type 1 (insulin-dependent) diabetes and healthy subjects (1985) (19)
The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients. (2006) (19)
Enrichment of Human Epidermal Langerhans Dendritic Cells (1984) (19)
Antigens on Human Fibroblasts Demonstrated with HL‐A Antisera and Anti‐Human Lymphocytic Sera (1968) (19)
Human Ia‐Like Antigens Associated with HLA‐D (1977) (19)
T lymphocyte responses to Coxsackie B4 and mumps virus. I. Influence of HLA-DR restriction elements. (2008) (19)
HLA‐D/DR Restriction of Langerhans Cell‐Dependent Antigen Activation of T Lymphocytes (1982) (19)
C4 HAPLOTYPE PRODUCTS AND PARTIAL INHIBITION OF ANTI‐RODGERS SERA (1981) (19)
Norwegian Sami differs significantly from other Norwegians according to their HLA profile. (2010) (19)
Mucosal and systemic immune response patterns in celiac disease. (1983) (19)
Requirements for Phytohaemagglutinin Activation of Resting Pure CD4+ and CD8+ T Cells (1988) (19)
Role of Accessory Cells in the Activation of Pure T Cells via the T Cell Receptor‐CD3 Complex or with Phytohaemagglutinin (1988) (18)
The HLA-DQ(alpha 1*0102, beta 1*0602) heterodimer may confer susceptibility to multiple sclerosis in the absence of the HLA-DR(alpha 1*01, beta 1*1501) heterodimer. (1997) (18)
Effect of pretransplant donor-specific transfusions in renal transplantation. (1982) (18)
Involvement of HLA in T-cell immune responses. (1981) (18)
HLA‐D‐restricted Antigen Activation of Sensitized T Lymphocytes: Studies on the Ability of HLA‐D/DR‐expressing B Lymphocytes to Substitute for Macrophages in Antigen Activation (1979) (18)
HL-A haplotype frequencies in Denmark and Norway. (2008) (18)
T‐Lymphocyte Activation by a Gluten Fraction, Glyc‐Gli (1983) (18)
T cells recognizing an HLA-DQ αß heterodimer encoded in Cis by the DR4DQw4 haplotype and in Trans by DR4DQw8/DRw8DQw4 heterozygous cells (1991) (18)
Studies of Synergism and Gene‐Dose Effect 1 (1970) (18)
Clonal distribution of HLA-restricted antigen-reactive T cells in man (1979) (18)
T cells recognize a peptide derived from alpha-gliadin presented by the celiac disease-associated HLA-DQ (alpha 1*0501, beta 1*0201) heterodimer. (1994) (18)
HL-A antigens and genes. 3. Production of HL-A typing antisera of desired specificity. (1969) (18)
HL‐A Antigens and Genes (1969) (18)
The inhibitory effect of HL-A antibodies on lymphocyte transformation in vitro. (1973) (17)
The HL‐A Transplantation System (1971) (17)
Complement loci of the HLA complex. Studies on families with intra-HLA crossovers and haplotype associations. (1981) (17)
HLA-DQ2-restricted T-cell recognition of gluten-derived peptides in celiac disease. Influence of amino acid substitutions in the membrane distal domain of DQ beta 1*0201. (1995) (17)
Genetic variants of the HLA-A, HLA-B and AIF1 loci show independent associations with type 1 diabetes in Norwegian families (2009) (17)
IDDM susceptibility associated with polymorphisms in the insulin gene region A study of blacks, Caucasians and orientals (1994) (17)
EFFECT OF BLOOD TRANSFUSIONS ON RENAL TRANSPLANTATION: STUDY OF 191 CONSECUTIVE FIRST TRANSPLANTS FROM LIVING RELATED DONORS (1980) (17)
T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection. (1993) (17)
Significance of HLA matching in renal transplantation. A prospective one-center study of 485 transplants matched or mismatched for HLA-A, B, C, D, and DR antigens. (1979) (17)
Novel HLA-DR2 and -DR3 haplotypes among Norwegian Caucasians. (1991) (17)
Polymorphisms in the gene encoding thymus-specific serine protease in the extended HLA complex: a potential candidate gene for autoimmune and HLA-associated diseases (2002) (17)
POSITIVE SELECTION OF Tac‐ (CD25) POSITIVE CELLS FOLLOWING T‐CELL ACTIVATION: USE OF IMMUNOMAGNETIC SEPARATION AND IMPLICATIONS FOR T‐CELL CLONING (1989) (17)
The role of HLA matching in renal transplantation: experience from one center. (1999) (17)
Molecular basis and functional importance of some disease-associated HLA polymorphisms. (1989) (16)
Production of blastogenic factor by mitomycin-treated cells in mixed lymphocyte cultures. (1974) (16)
In vitro cytotoxicity by human lymphocytes from individuals immunized against histocompatibility antigens. II. Relation to HL-A incompatibility between effector and target cells. (1970) (16)
Polymorphism of the HL-A system. (1971) (16)
Influence of genetic factors (HLA class II genes, insulin-gene region polymorphisms) and metabolic control on the development of diabetic nephropathy. (1993) (16)
Analysis of alloreactive helper T lymphocyte precursor frequencies. Influence of interleukin-2 produced by the stimulating cells. (1996) (15)
T cell receptor usage by HLA-DQw8-specific T cell clones. (1992) (15)
Influence of HLA matching in cadaveric renal transplantation: experience from one Scandiatransplant center. (2008) (15)
HLA class-II restriction of antigen-specific T-cell activation. With special reference to the fine specificity and immunoregulation of HLA class-II restriction elements. (1985) (15)
Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(alpha 1*0501, beta 1*0201) molecule. (1994) (15)
Immunogenicity of foreign tissues. (1981) (15)
[Transplantation medicine in Norway through 50 years]. (2006) (15)
Morbidity risk factors in human cardiac transplantation. Histoincompatibility and protracted graft ischemia entail high risk of rejection and infection. (1992) (15)
Inhibition of human mixed lymphocyte culture stimulation by anti‐HLA‐D ‐associated antisera: studies with primed responding cells (1977) (15)
HL-A polymorphism of Norwegian Lapps. (2008) (15)
Identification, at the genomic level, of an HLA-DR restriction element for cloned antigen-specific T4 cells (1985) (15)
Genetics of the HL-A System (1970) (15)
IgG heavy chain (Gm) allotypes in rheumatoid arthritis and in healthy individuals seropositive for IgM-rheumatoid factor. (1985) (14)
T‐Cell Recognition of HLA Class II Molecules Induced by Gamma‐Interferon on a Colonic Adenocarcinoma Cell Line (HT29) (1990) (14)
Genetic Evidence for a Contribution of Native Americans to the Early Settlement of Rapa Nui (Easter Island) (2016) (14)
The human mixed-lymphocyte culture (MLC) interaction after in vivo allo-immunization. II. HL-A specificity of early proliferative response. (1974) (14)
HLA-DQw3.1 and DQw3.2 associated exon polymorphisms detected by oligonucleotide probes. (1988) (13)
HL-A haplotypes and their inheritance. (1971) (13)
On the future of HLA. (2011) (13)
In vitro foeto-maternal lymphocyte responses at delivery: no gross changes in MLC and PLT responsiveness. (1980) (13)
Immunopathology of gluten-sensitive enteropathy (2004) (13)
Donor age and cumulative kidney graft survival. (2008) (13)
MHC structure and function. (1999) (13)
HLA associations in type 1 diabetes: DPB1 alleles may act as markers of other HLA-complex susceptibility genes. (2003) (13)
The prevalence of HLA-DR4 and HLA-DR3 in healthy persons with rheumatoid factor. (1985) (12)
Immunologic monitoring of rabbit antithymocyte globulin-treated transplant recipients: a comparison of serial E-RFC and immunomagnetic quantitation of CD2+ cells. (1988) (12)
HLA-D/DR restriction of proliferative T cell responses to antigen. Enrichment of antigen-specific T cell blasts and evidence of preferential HLA-D/DR restriction. (2008) (12)
Relative efficiency of human Langerhans' cells and blood derived dendritic cells as antigen-presenting cells. (1985) (12)
Antigen-specific T cells restricted by HLA-DQw8: Importance of residue 57 of the DQβ chain (1990) (12)
Correlation between HLA-DR mismatch and rejection episodes in cardiac transplantation. (1987) (12)
The effect of blood transfusions on renal transplantation. Studies of 395 patients registered for transplantation with a first cadaveric kidney. (2008) (12)
HLA class II profile of a Polish population: frequencies of DRB1, DQA1, DQB1, and DPB1 alleles and DRB1-DQA1-DQB1 haplotypes. (1996) (12)
HL-A antigens and genes. I. A study of unrelated Norwegians. (1969) (12)
Structural complement factor loci and the HLA region. (1978) (12)
Influence of HLA-A, B, C, D, and DR matching in renal transplantation. (1981) (12)
The Role of Human Class II Molecules in Activation of T4 Lymphocytes (1986) (12)
Specificity of antibodies that inhibit the MLC response. (1973) (12)
Insulin dependent diabetes mellitus susceptibility or protection may be determined by certain HLA-DQ molecules. (1991) (12)
Vaccination of children with malignant disease against varicella. (1985) (12)
HLA Control of the Proliferative T Lymphocyte Response to Antigenic Determinants on Mumps Virus (1985) (12)
Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens. (1986) (12)
Positive selection of bone marrow-derived CD34 positive cells for possible stem cell transplantation. (1993) (12)
The presence of HLA-D determinants on human skin cells. (1976) (12)
T cell-epithelium interactions in relation to gut immunity. (1988) (11)
T-Cell clones with similar antigen specificity may be restricted by DR, MT (DC), or SB class II HLA molecules (2004) (11)
Characterization of a monoclonal antibody recognizing a polymorphic epitope mainly on HLA-DPw2 and DPw4 molecules. (1989) (11)
Physical separation of HLA-A alleles by denaturing high-performance liquid chromatography. (2003) (11)
Recognition of an HLA-DPw1 specific alloantiserum raised by planned immunization. (1986) (11)
Both alpha and beta chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. (1996) (11)
CELL‐MEDIATED CYTOTOXICITY TOWARD THE DONOR IN PATIENTS WITH WELL‐FUNCTIONING KIDNEY GRAFTS: POSSIBLE MECHANISM OF SPECIFICALLY REDUCED CYTOTOXIC RESPONSE (1983) (11)
Identification and significance of products of the HLA-D region. (1978) (10)
HLA and epidermolysis bullosa. (1977) (10)
Recognition of a particular HLA-DQ heterodimer by a human gamma/delta T cell clone. (1990) (10)
Donor-specific decreased primary and secondary cell-mediated immune responses in patients with well functioning grafts. (1981) (10)
Significance of HLA-DR matching and of B cell crossmatch tests in vitro and in cadaver renal transplantation. (1979) (10)
A haemolytically non-active C4 gene product. (1980) (9)
Nonlinkage between C6 and chromosome 6 markers (1977) (9)
HLA antigens in malignant melanoma (1977) (9)
T-cell receptor beta usage by 35 different antigen-specific T-cell clones restricted by HLA-Dw4 or -Dw14.1. (1992) (9)
Pepsinogens: new variant and linkage relationships to chromosome 6 markers. (1978) (9)
Stimulation of human lymphocytes by cultured allogeneic skin and endothelial cells in vitro. (1975) (9)
SPECIFICITY OF HUMAN LYMPHOCYTES PROLIFERATING IN RESPONSE TO ALLOGENEIC AND XENOGENEIC CELLS IN VITRO (1974) (9)
The Role of the CD8‐Positive Subset of T Cells in Proliferative Responses to Soluble Antigens (1986) (9)
Evidence of a third HL-A locus. (1973) (9)
Risk factors for total and cause-specific mortality in human cardiac transplantation. Prolonged extracorporeal bypass time: a high risk factor for rejection and infection. (1991) (9)
Results of the National Kidney Transplantation Program in Norway. (1992) (9)
Sequences of four previously undescribed human T-cell receptor beta chain variable genes. (1991) (9)
Report from a post-workshop exchange of HLA--D typing cells. (2008) (8)
DNA Restriction Fragment Length Polymorphism of Some Ninth Workshop Homozygous Typing Cells Using a cDNA Probe Specific for DRβ (1984) (8)
Human complement‐activating immunoglobulin (Ig)G3 antibodies are essential for porcine endothelial cell activation (2006) (8)
Human endothelial cells can present antigen to sensitized T lymphocytes in vitro. (1981) (8)
New HL-A alleles. Identification by planned immunization. (1970) (8)
Binding of Ras Oncogene Peptides to Purified HLA‐DQ(αl*0102, ß1*0602) and ‐DR(α, ß1*0101) Molecules (1994) (8)
Serological typing of HLA-D: Predictive value in mixed lymphocyte cultures (MLC) (1978) (8)
Immunomagnetic isolation of cells for serological BoLA typing. (2009) (8)
Isolation of functionally active T cell receptor γδ-bearing lymphocytes from human peripheral blood (1989) (8)
Homologies between the H-2 and HL-A systems. (2008) (8)
Genetic polymorphism of the second component of human complement (C2) (1978) (8)
Antibody-induced cell-mediated damage to human endothelial cells in vitro (1975) (8)
An additional susceptibility gene for juvenile idiopathic arthritis in the HLA class I region on several DR-DQ haplotypes. (2003) (8)
A simple and sensitive bioassay for the detection of IL-2 activity. (1988) (8)
The influence of HLA-A, -B, -C, and -D matching on kidney graft survival. (1977) (8)
Specificity of responding cell populations in mixed lymphocyte cultures. (1973) (8)
Epitopes on HLA-DQw3 Molecules Recognized by T-Lymphocyte Clones (1989) (7)
Determination of the HLA-DR profile of an HLA class II negative carcinoma cell line by restriction fragment length polymorphism (RFLP) analysis. (2008) (7)
Dw14 is a Dw4-independent risk factor for rheumatoid arthritis among Norwegians. (1992) (7)
Human heart transplantation. Rejection risk factors. (1988) (7)
Coding region polymorphisms of human T-cell receptor V beta 6.9 and V beta 21.4. (1992) (7)
HLA Class-II Restriction of Antigen-Specific T-Cell Activation (1985) (7)
Human serum‐induced porcine endothelial cell E‐selectin expression is associated with IgG3 and IgM anti‐Gal antibodies (2002) (7)
Which antigens on skin cells cause allogeneic stimulation of lymphocytes in vitro? (1973) (7)
Cell mediated lympholysis; a modified technique using 111indium-oxine-labelled targets. (1983) (7)
The role of serum in human mixed lymphocyte cultures. (1975) (7)
Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing. (1993) (7)
DONOR‐SPECIFIC DECREASED CELL‐MEDIATED CYTOTOXICITY IN RECIPIENTS OF WELL FUNCTIONING, ONE HLA HAPLOTYPE‐MISMATCHED KIDNEY ALLOGRAFTS (1983) (7)
HLA-DR-DQ haplotype frequencies in a Norwegian population. (1992) (7)
HISTOCOMPATIBILITY ANTIGENS CAUSING STIMULATION IN MIXED LYMPHOCYTE CULTURE INTERACTIONS ANTIGENIC IDENTITY OR SIMILARITY BETWEEN INDIVIDUALS (1973) (7)
The Role of Langerhans cells in the Pirquet and Moro‐Hamburger tuberculin reactions (1980) (7)
HL-A antigens and genes. II. Studies of the antigen MH (=HL-A5) of the 4 sub-locus. (1969) (7)
Characterization and epitope mapping of four HLA class II reactive mouse monoclonal antibodies using transfected L cells and human cells transfected with mutants of DQB1*0302. (1995) (7)
Association analysis in type 1 diabetes of the PRSS16 gene encoding a thymus-specific serine protease. (2007) (7)
Recognition of allogeneic cis- or trans-encoded HLA-DQ molecules both by alpha beta and gamma delta T-cell receptors. (1991) (6)
Radiosensitivity of non-primed and primed human T cells in vitro. (1980) (6)
The national kidney transplant program in Norway still results in unchanged waiting lists. (1998) (6)
SUPPRESSOR-CELL ACTIVITY IN COELIAC DISEASE (1985) (6)
HLA-B27 and allotypes of complement components in ankylosing spondylitis. (1984) (6)
HLA antigens in malignant melanoma. (1977) (6)
HLA-DR typing and B cell cross-match tests in cadaveric renal transplantation. (1980) (6)
Role of HLA molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era. (2004) (6)
Influence of HLA-A, B, C, and D matching and pretransplant blood transfusions on kidney graft survival. (1979) (6)
HLA‐DR matching reduces rejection rate in heart transplantation (1996) (6)
Antibody induced cell-mediated cytotoxicity. Studies of human alloantibodies in a micro-plate-test. (2008) (6)
Heterogeneity of T cells specific for a particular peptide/HLA-DQ complex. (1994) (5)
Influence on antibody recognition of amino acid substitutions in the cleft of HLA-DQ2 molecules. Suggestive evidence of peptide-dependent epitopes. (1995) (5)
Prevalence of antibodies to herpes simplex virus and frequency of HLA antigens in patients with preinvasive and invasive cervical cancer. (1984) (5)
Serologic recognition of HLA-D-associated determinants. (1977) (5)
Oncogene-derived peptides: a new class of tumor rejection antigens? (1993) (5)
Specificity of human lymphocytes primed against allogeneic cells in vitro. 1. Optimalization of culture conditions for detection of HLA--D specificity. (1978) (5)
Close association between the Dw14 (LD40) subtype of HLA-DR4 and a Restriction element for antigen-specific T-cell clones (2004) (5)
C1-inhibitor attenuates human serum induced E-selectin expression of pig aortic endothelial cells. (2001) (5)
Possibility of a third sublocus. (1971) (5)
Inhibition of in vitro lymphocyte transformation by HL-A antibodies. (1973) (5)
Further investigations on the genetics of the C+ protein polymorphism. (1980) (5)
Ability of Pure Resting CD8+ Human T Cells to Respond to Alloantigen (1989) (5)
Renal transplantation from living donors mismatched for two HLA haplotypes. (1987) (5)
Monozygotic Twins Display Differences in Their Allospecific Cytotoxic T‐Cell Repertoire (1996) (5)
Relationship of HLA--D associated B lymphocyte (Ia-like) antigens in the cell membrane. (1978) (5)
Cyclosporine in living related and cadaveric renal transplantation. (1984) (5)
HUMAN T CELL RESPONSE TO HERPES SIMPLEX VIRUS ANTIGEN IN VITRO (1980) (5)
Self-HLA-D-Region Products Restrict Human T-Lymphocyte Activation by Antigen (1981) (5)
[Genetic diagnostic test for hemochromatosis]. (1998) (5)
Interleukin 2- and interferon-production and expression of interleukin 2 receptors by human mononuclear cells stimulated with mumps virus or phytohaemagglutinin. (2009) (5)
The response of alloimmune human lymphocytes in mixed lymphocyte culture tests. (1973) (5)
FURTHER CHARACTERIZATION OF HUMAN SUPPRESSOR CELLS GENERATED IN MIXED LYMPHOCYTE CULTURES (1980) (5)
Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102, beta 1*0602) and -DR (alpha, beta 1*0101) molecules. (1994) (4)
The HLA-D determinants (1977) (4)
Particular HLA-DQ alpha beta heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8/DRw8-DQw4 whites. (1991) (4)
Transplantation immunology--the role of human leucocyte antigen in allorecognition. (1999) (4)
Induction of Interleukin‐2 Production in CD4+ and CD8+ T‐Cell Subsets after Activation via CD3 and CD2 (1988) (4)
Transplantation immunology: a brief update. (1997) (4)
Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant. (1992) (4)
HLA-restricted cell-mediated cytotoxicity directed against male specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney. (1981) (4)
Alloreactive T cells recognizing determinants dependent on the DQ beta chain of DQw2. (1989) (4)
Cytotoxic HL-A Antibodies (1970) (4)
Analysis of infiltrating lymphocytes from fine needle aspiration biopsies in kidney transplant patients by a rapid and sensitive immunomagnetic method. (1989) (4)
Antilymphocyte globulin in cadaveric renal transplantation--a controlled trial. (1977) (4)
Serologic subtyping of HLA-DR8 by means of the cytotoxic human monoclonal antibody 5643. (1995) (4)
HLA in anthropology: the enigma of Easter Island. (2013) (4)
Partial DNA sequences derived from two previously unknown HLA class I genes. (1991) (4)
Detection of HLA-D region products by primed lymphocyte typing (PLT). (1981) (4)
Donor-specific cytotoxic T cells recovered from transvenous biopsies after clinical heart transplantation. (1988) (4)
[Diabetes mellitus--a complex interaction between heredity and environment]. (1998) (4)
Immunomagnetic tissue typing offers new possibilities in cadaveric transplant donor-recipient HLA matching. (1988) (4)
Influence of HLA matching on kidney graft survival. (1975) (4)
The cytotoxic HLA-DQ3 reactive human hybridoma antibody 4166 that may distinguish DQ7 + 8 from DQ9. (1995) (4)
CYTOTOXIC T CELLS RECOGNIZING MINOR TRANSPLANTATION ANTIGENS, AND POSSIBLY A VARIANT OF THE HLA‐B8 MOLECULE: CAUSE OF REJECTION OF AN HLA‐IDENTICAL SIBLING KIDNEY TRANSPLANT? (1984) (3)
Antigen Report: HLA-DR3 (1984) (3)
Genomic HLA-DRB1 matching further improves clinical course after renal transplantation. (1995) (3)
Insulin autoimmune syndrome; HLA genes may be a marker of disease heterogeneity. (1993) (3)
T cells specific for viral antigens presented by HLA-Dw4 recognize DR13 on allogeneic cells: a possible mechanism for induction of rejection. (1993) (3)
Anti-MHC xenoantisera and alloterminology. (1977) (3)
No evidence of type 1 diabetes susceptibility genes in the region centromeric of the HLA complex. (2003) (3)
HLA and Gastrointestinal Diseases (2000) (3)
Allorecognition of HLA-DQw8 molecules: influence of single amino acid substitutions. (1992) (3)
Cytotoxic HL-A antibodies. Studies of synergism and gene-dose effect. (1970) (3)
The T-cell receptor: does it stimulate allogeneic lymphocytes in MLC? (1973) (3)
Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance. (1987) (3)
Specificity of human lymphocytes primed against allogeneic cells in vitro. II. Discrimination and cross-reactivity in repeated priming. (2008) (3)
[Immunologic reactions in transplantation]. (1999) (3)
The role of HLA compatibility in renal transplantation from living donors: an analysis of 379 grafts. (1990) (3)
HLA haplotypes in multiple case families with rheumatoid arthritis (1984) (3)
Specificity of human histocompatibility antigen reactive cells in vitro. Separate cell populations responsive to the products of each major histocompatibility system (MHS) haplotype. (1974) (3)
A comparison of serial E-RFC monitoring and immunomagnetic quantitation of CD2+ cells in RATG-treated transplant recipients. (1988) (3)
HLA and non-HLA phenotyping and genotyping in Austral and Gambier Polynesian Archipelagos. (2008) (3)
Important of HLA matching in cadaveric renal transplantation. A prospective one-center study. (1981) (3)
Joint Report from a Mixed Lymphocyte Culture Workshop (2008) (3)
No extreme genetic risk for type 1 diabetes among DR3/4-DQ8 siblings sharing both extended HLA haplotypes with their diabetic proband. (2011) (3)
Specificity and genetics of alloantigens which can be recognized by primed lymphocyte typing (PLT) in man: Chairman summary of session I of the second international conference on the primed lymphocyte☆ (1981) (3)
HLA-antigens in patients with allergic contact sensitivity to nickel (2004) (3)
Joint report from a workshop on methods for identification of human B lymphocyte (Ia-like) alloantigens. (2008) (2)
The role of human endothelial cells in allograft rejection. Some in vitro correlates. (1975) (2)
Preliminary results with passive enhancement in human kidney transplantation. (1975) (2)
Chido blood group and the HLA region. (1976) (2)
Synthesis of cytoplasmic and functional membrane SC induced by gamma-interferon. (1987) (2)
The mumps-specific T cell response in healthy individuals and insulin-dependent diabetics: preferential restriction by DR4-associated elements. (2009) (2)
The Structural C6 Polymorphism: Nonlinkage Between C6 and Chromosome 6 Marker Loci (1978) (2)
The HL-A transplantation system. Further evidence of antigenic heterogeneity. (1971) (2)
Juvenile idiopathic arthritis ( JIA ) is primarily associated with HLA-DR 8 but not DQ 4 on the DR 8-DQ 4 haplotype (2002) (2)
[112] GENETIC VARIATION IN THE RECEPTOR-LIGAND PAIR NKG2D-MICA IS STRONGLY ASSOCIATED WITH DEVELOPMENT OF CHOLANGIOCARCINOMA IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS (2007) (2)
A gene in the telomeric HLA complex distinct from HLA-A is involved in predisposition to juvenile idiopathic arthritis (JIA) (2002) (2)
Human histocompatibility matching. II. Calculated probability and clinical reality. (1974) (2)
The presence of Ia-like determinants on a subpopulation of human T lymphocytes (1977) (2)
Eular workshop on Rheumatology Research (1982) (2)
[Transplantation of animal organs (xenotransplantation). Status and future development]. (1997) (2)
A Structural Locus for Coagulation Factor XIIIA (F13A) is Located Distal to HLA on the Short Arm of Chromosome 6 in Man (1984) (2)
[Kidney transplantation in Norway]. (1990) (2)
HLA histocompatibility antigens and meningococcal disease. (1980) (2)
Specificity of Two Subsets of Cytotoxic Human γδ T‐Cell Clones (1990) (2)
Antigen-specific T cells restricted by HLA-DQw8: importance of residue 57 of the DQ beta chain. (1990) (2)
Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras (1994) (2)
Studies of the T-cell receptors of T cells recognizing the same HLA molecule. (1993) (2)
Influence of matching for HLA-DR in first cadaveric renal transplantation in nonsensitized recipients. (1997) (2)
' Gustav Gaudernack CD 8 + T cells from a patient with colon carcinoma , specific for a mutant p 21-Ras-derived peptide ( GLY 13 ASP ) , are cytotoxic towards a carcinoma cell line harbouring the same mutation (2)
Heart transplantation in Norway. One-year experience. (1985) (2)
[Kidney transplantation in chronic renal failure]. (1977) (2)
Expression of HLA class II molecules on human monocytes and dendritic cells (1984) (2)
HLA-D determinants are responsible for stimulation of lymphocytes by allogeneic macrophages in vitro. (1977) (2)
HLA-D restriction of antigen-specific proliferative T cell responses. Inhibitory activity of antisera against HLA determinants or stimulatory antigen. (2008) (2)
Pretransplant immunologic considerations. (1984) (2)
Controlled trial of antilymphocyte globulin in cadaveric transplantation. (1976) (2)
[Kidney transplantation at Ullevål hospital. A 7 year material]. (1971) (1)
Genetisk diagnostisk test for hemokromatose (1998) (1)
The HLA complex. Some recent developments. (1977) (1)
The HLA molecules: function and role in allorecognition. (1994) (1)
Identification in blood stains through DNA typing with C4 and HLA-DR probes. (1987) (1)
The Frequency of Major Histocompatibility Antigens (SD & LD) in Thyrotoxicosis (2008) (1)
History of HLA (2010) (1)
HLA class II profile of a human carcinoma cell line: Detection on genomic level and after exposure to γ-interferon (1987) (1)
Power of molecular genetics amply confirmed. (1983) (1)
Does genomic HLA-DR matching further enhance the effects of serologic DR matching in clinical renal transplantation? (1994) (1)
Effect of pre-transplant blood transfusions and haemodialysis on the survival of first kidney grafts from living related donors. (1980) (1)
T cells recognizing an HLA-DQ alpha beta heterodimer encoded in cis by the DR4DQw4 haplotype and in trans by DR4DQw8/DRw8DQw4 heterozygous cells. (1991) (1)
Studies on the HLA association to insulin-dependent diabetes mellitus (IDDM). (1988) (1)
HLA-DRw4 and rheumatoid arthritis. (1979) (1)
Antigen Society #32 Report (DP) (1989) (1)
Experience with cyclosporine in 1519 kidney transplantations from living donors in a national transplant programme, 1983-2002. (2004) (1)
A Simple and Rapid Procedure for Purification of Human Dendritic Cells from Peripheral Blood (1984) (1)
A novel juvenile idiopathic arthritis (JIA) susceptibility gene in HLA class I region marked by microsatellite D6S265 (2003) (1)
Genetic linkage relation of the pepsinogen Pg5 locus (1980) (1)
The Role of the CD8‐Positive Subset of T Cells in Proliferative Responses to Soluble Antigens (1986) (1)
Histocompatibility antigens immunogenetics and role of matching in clinical renal transplantation. (1981) (1)
The HL‐A Antigen, LND (‐W15) (1971) (1)
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF CYTOTOXIC AGENTS CONJUGATED TO ANTIHUMAN LYMPHOCYTE GLOBULIN (1978) (1)
Donor-Specific Decreased Cell-Mediated Cytotoxicity in Recipients of Well Functioning, One HLA Haplotype-Mismatched Kidney Allografts (1983) (1)
Histocompatibility. Influence of HLA-DR matching on renal graft survival. A Scandiatransplant report. (1981) (1)
Jejunal epithelium of patients with coeliac disease shows enhanced expression of MHC class II subregion products. (1988) (1)
HL‐A Antigens and Genes (1969) (1)
ADCC detects a public B-cell specificity broader than DRw3 and DRw6. (1978) (1)
Isolation of functionally active T cell receptor gamma delta-bearing lymphocytes from human peripheral blood. (1989) (1)
P94 - The presence of gliadin specific, HLA DQ2 restricted T cells in the small intestinal mucosa is a common phenomenon of celiac disease (1996) (1)
Changing the priority for HLA matching in kidney transplantation. (2004) (1)
[The Nobel Prize in physiology and medicine 1996. What are we going to do with tissue typing?]. (1996) (0)
[Norwegian nomenclature in immunology]. (1989) (0)
Structural Variability in Human C4: Methodological and Genetic Data (1978) (0)
Induction of specific unresponsiveness to allogeneic tissue: an introduction. (1977) (0)
HLA restriction fine-specificity and T-cell receptor usage of T cells recognizing DQ7. (1994) (0)
DR antigens and gold toxicity (0)
The new pathology building at Rikshospitalet, Oslo 1972. (1972) (0)
A Mixed Lymphocyte Culture Micro‐Technique and its Application in Different Family and Unrelated Combinations (2008) (0)
Specificity of gamma delta receptor-bearing cytotoxic T lymphocytes isolated from human peripheral blood. (1989) (0)
[HLA and illness]. (1976) (0)
[Vaccination of immunosuppressed children against varicella]. (1984) (0)
[Editorial: Immunology and cancer]. (1976) (0)
[The molecular basis of genetic variation in man]. (1970) (0)
[HLA molecules and disease predisposition]. (1989) (0)
O75 - Motif for HLA-DQ2 (α1*0501, β1*0201): Evidence for anchors at positions one, four, six, seven and nine (1996) (0)
[Stem cell transplantation--more than bone marrow transplantation]. (1995) (0)
[Transplantation immunology]. (1971) (0)
INHIBITION OF THE HUMAN MIXED LYMPHOCYTE CULTURE (MLC) INTERACTION BY CYTOTOXIC AGENTS CONJUGATED TO ANTI-LYMPHOCYTE GLOBULIN (1977) (0)
Abstract session I–Transplantation (2004) (0)
Brief Definitive Report Inhibition of the Fc Receptor of Human Lymphoid Cells by Antisera- Recognizing Determinants of the Hla System* the Journal of Experimental Medicine @bullet Volume (2003) (0)
Involvement of HLA Cell Membrane Molecules in T Cell Immune Responses (2019) (0)
Bone marrow transplantation (BMT) with unrelated donors in Norway (1996) (0)
[Side effects in gold therapy]. (1983) (0)
Enrichment and functional studies on human langerhans cells (1983) (0)
Subject Index Vol. 16, 1976 (1976) (0)
Restriction Elements on Class II HLA Molecules Studied by Cloned Human T4 Cells (1985) (0)
The Molecular Basis of the HLA Association in Celiac Disease (1997) (0)
The cytotoxic human hybridima antibody 5643 recognizes a sub-group of HLA-DR8 molecules (1994) (0)
Antigen Society Report #32 HLA-DP. (1989) (0)
Close association between Fc receptor and HLA-D-associated (Ia-like) determinants on human lymphoid cells. (1977) (0)
Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction. (1983) (0)
Identification in blood stains through DNA typing with C4 and HLA-DR probes (2004) (0)
Chido blood group and the HLA region. (1976) (0)
Cellular and humoral immunity after clinical renal transplantation. (1975) (0)
Gliadin-specitlc, ~I*0201) Restricted T Cells Isolated from the Small Intestinal Mucosa of Celiac Disease Patients By Knut E. A. Lundin,* Helge Scott,~ Torbjern Hansen,* (1993) (0)
[Human histocompatibility antigens (HL-A-antigens). Genetic studies and identification of "new" HL-A-antigens]. (1970) (0)
[HL-A typing in disease diagnosis]. (1978) (0)
Preface (1970) (0)
Cell-mediated rejection of kidney transplant after passive enhancement. (1973) (0)
Antigen-Specific T Cell Clones Restricted by DR, DQ, or DP Class II HLA Molecules (1984) (0)
Cloned Cytotoxic T Cells Which May Define a Minor Transplantation Antigen and a Variant of the HLA-B8 Molecule (1984) (0)
[HLA-antigen (human leukocyte antigens) and rheumatoid arthritis. Relation to the etiology of the disease?]. (1980) (0)
[Gene technology in immunologic research, diagnosis and treatment]. (1989) (0)
HLA Matching in Clinical Organ Transplantation (1993) (0)
Editorial (1986) (0)
Immunogenetic difference between juvenile and adult ankylosing spondylitis (1994) (0)
Subject Index Vol. 22, 1978 (1978) (0)
[Clinical transplantation immunology]. (1973) (0)
Contents, Vol. 62, 1980 (1980) (0)
Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules. (1994) (0)
13th IHWS Disease Component Joint Report: D6. The 13th International Histocompatibility Working Group for Celiac Disease Joint Report (2006) (0)
Role of HLA-DQ2 and -DQ8 as Susceptibility Molecules in Coeliac Disease — A Model-Disease of Autoimmunity (1994) (0)
Lack of association between the chemokine receptor 5 polymorphism CCR 5 ∆ 32 in rheumatoid arthritis and juvenile idiopathic arthritis (2006) (0)
[Immunological evaluation of patients for transplantation]. (1971) (0)
Effect of blood transfusions on first cadaveric graft and uremic patient survival. (1980) (0)
[OXYURIASIS. INCIDENCE AND SYMPTOMATOLOGY IN CHILDREN]. (1964) (0)
[Editorial: Histocompatibility antigens and disease]. (1975) (0)
The effect of 3-4 HLA-A and -B antigen mis-matched cadaveric kidney transplants on graft and patient survival. (1980) (0)
Bf locus and the HLA region. (1976) (0)
Relevance of HLA-D/-DR Matching in a National Kidney Transplant Program (1986) (0)
HLA class II profile of a human carcinoma cell line: detection on genomic level and after exposure to gamma-interferon. (1987) (0)
[Easter Island--early genetic traces after American Indians]. (2010) (0)
Tenth Meeting of the Scandinavian Society for Immunology (1979) (0)
HLA DR antigens andgoldtoxicity (1983) (0)
Some possible mechanisms leading to autoimmune destruction of bone marrow cells. (1979) (0)
HLA antigens and T cell receptors (1996) (0)
Bf locus and the HLA region. (1976) (0)
A Disposable Tray for Micro‐Droplet Tissue Typing (1971) (0)
[Norwegian policy on alcohol use and the Norwegian Medical Society]. (1997) (0)
3 A MICRO-METHOD FOR DETECTION OF THROMBOCYTE ANTIBODIES (1979) (0)
Predisposition to Insulin-Dependent Diabetes Mellitus: Role of HLA and non-HLA Genes (1994) (0)
The C2 Polymorphism: Its Genetics and Presentation of Typing Technique Modifications (1978) (0)
[Quantification of T-lymphocyte subpopulations. Immunological marker in human immunodeficiency virus infections]. (1991) (0)
REPORT ON THE WORKSHOP: “PRIMARY AND SECONDARY STIMULATION IN MLR AND CML” (1976) (0)
Renal transplantation from HLA-haploidentical living donors. Efficacy of cyclosporine in a multicenter study. (1987) (0)
Inhibition of complement and xenogeneic endothelial cell activation by compstation (1998) (0)
P87 - Both the α- and the β-chain determine the peptide binding specificity of HLA-DQ2 (1996) (0)
Function of DQ2 and DQ8 as susceptibility molecules in coeliac disease (1994) (0)
Contribution genetics to the understanding of coeliac disease (2003) (0)
[The importance of a good HLA match]. (1994) (0)
[Transplantation immunology in allogeneic bone marrow transplantation. The significance of HLA-tissue crossmatching between donors and recipients]. (1994) (0)
Antigenic Products of the HLA-D Region (1981) (0)
Scandiatransplant’s 50th jubilee – a successful Nordic collaboration on organ transplantation. (2019) (0)
Presentations at the annual meeting of the Norwegian Society for Rheumatology in Oslo, 28 November 2001 (2002) (0)
Editorial. Launching a new medical journal. (1971) (0)
The Nobel Prize in Medicine 1996 (1996) (0)
In memoriam (2004) (0)
Cell-mediated lympholysis. A modified assay using inhibition of DNA synthesis by lymphoblastoid target cells. (1977) (0)
Diabetes mellitus - et komplekst samspill mellom arv og miljø (1998) (0)
[Allogeneic bone marrow transplantation in Norway]. (1987) (0)
Annals of the Rheumatic Diseases , 1983 , 42 , 63-66 HLA DR antigens and gold toxicity (2003) (0)
HLA antigens in survivors of childhood acute lymphoblastic leukaemia (1984) (0)

This paper list is powered by the following services:

Other Resources About Erik Thorsby

en.wikipedia.org

What Schools Are Affiliated With Erik Thorsby?

Erik Thorsby is affiliated with the following schools:

University of Oslo